pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,994 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: pdufa×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Week of Feb 2, 2026

    49
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

    Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

    Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

    full page →(alendronate sodium + cholecalciferol) →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 4, 2026approval207d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Feb 4, 2026approval207d agoCARBOPLATIN — FDA approvalOncotelic Therapeutics, Inc.

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoAZTREONAM — FDA approvalAZTREONAM

    Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION

    full page →AZTREONAM →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: SAGENT PHARMS INC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoNICOTINE POLACRILEX — FDA approvalPL Developments Copiague LLC

    Sponsor: P AND L. Form: GUM, CHEWING. Route: BUCCAL

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoNYSTATIN — FDA approvalActavis Mid Atlantic LLC

    Sponsor: STERANCO HLTHCARE. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: KINDOS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoBUMETANIDE — FDA approvalBUMETANIDE

    Sponsor: MSN. Form: TABLET. Route: ORAL

    full page →BUMETANIDE →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: EUGIA PHARMA SPECLTS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoPRUCALOPRIDE SUCCINATE — FDA approvalSpecGx LLC

    Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoCARBIDOPA, LEVODOPA AND ENTACAPONE (CARBIDOPA) — FDA approvalcarbidopa

    Sponsor: ALEMBIC. Form: TABLET. Route: ORAL

    full page →carbidopa →fda approvals ↗
    ›Feb 5, 2026approval206d agoMYQORZO (AFICAMTEN) — FDA approvalaficamten

    Sponsor: CYTOKINETICS. Form: TABLET. Route: ORAL

    full page →aficamten →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoHYDROCORTISONE SODIUM SUCCINATE — FDA approvalHYDROCORTISONE SODIUM SUCCINATE

    Sponsor: APOTEX. Form: INJECTABLE. Route: INJECTION

    full page →HYDROCORTISONE SODIUM SUCCINATE →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalExtrovis AG

    Sponsor: NOVAST LABS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 5, 2026approval206d agoZOLEDRONIC ACID — FDA approvalZOLEDRONIC ACID

    Sponsor: GLAND. Form: INJECTABLE. Route: INTRAVENOUS

    full page →ZOLEDRONIC ACID →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: ALEMBIC. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 5, 2026approval206d agoFLUOROURACIL — FDA approvalEfudex

    Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION

    full page →Efudex →fda approvals ↗
    ›Feb 6, 2026approval205d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: BARR LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 6, 2026approval205d agoOLANZAPINE AND FLUOXETINE HYDROCHLORIDE (FLUOXETINE HYDROCHLORIDE) — FDA approvalFLUOXETINE HYDROCHLORIDE

    Sponsor: EPIC PHARMA LLC. Form: CAPSULE. Route: ORAL

    full page →FLUOXETINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 6, 2026approval205d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: PH HEALTH. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 6, 2026approval205d agoIDARUBICIN HYDROCHLORIDE — FDA approvalIDARUBICIN HYDROCHLORIDE

    Sponsor: PFIZER. Form: SOLUTION. Route: INTRAVENOUS

    full page →IDARUBICIN HYDROCHLORIDE →fda approvals ↗
    ›Feb 6, 2026approval205d agoPRAVASTATIN SODIUM — FDA approvalSenores Pharmaceuticals Inc

    Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 6, 2026approval205d agoTICAGRELOR — FDA approvalTICAGRELOR

    Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

    full page →TICAGRELOR →fda approvals ↗
    ›Feb 6, 2026approval205d agoNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (NOREPINEPHRINE BITARTRATE) — FDA approvalNOREPINEPHRINE BITARTRATE

    Sponsor: BAXTER HLTHCARE CORP. Form: SOLUTION. Route: INTRAVENOUS

    full page →NOREPINEPHRINE BITARTRATE →fda approvals ↗
    ›Feb 6, 2026approval205d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Feb 6, 2026approval205d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗

    Week of Feb 9, 2026

    1
    ›Feb 9, 2026approval202d agoREGLAN (METOCLOPRAMIDE HYDROCHLORIDE) — FDA approvalANI PHARMACEUTICALS INC

    Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ← prev
    page 364 of 380
    next →
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $BAX25.93-2.15%
    $RDY12.18+0.16%
    $OGN13.760.00%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $OGN13.760.00%
    $OTLC0.0373-8.80%
    $CYTK72.09-7.46%
    $ANIP72.83-0.93%
    $PFE27.96-0.21%